Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
J. Dormandy, B. Charbonnel, D. Eckland, E. Erdmann +26 more

